Previous close | 30.80 |
Open | 31.06 |
Bid | 0.00 x 800 |
Ask | 35.00 x 800 |
Day's range | 30.86 - 31.52 |
52-week range | 25.77 - 40.28 |
Volume | |
Avg. volume | 2,014,398 |
Market cap | 4.263B |
Beta (5Y monthly) | 0.62 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.10 (3.48%) |
Ex-dividend date | 07 Mar 2024 |
1y target est | N/A |
Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that Opill® has shipped to major retailers and pharmacies and will be available on shelves nationwide and online later this month. Approved by the U.S. Food and Drug Administration (FDA) for OTC use for all ages in July 2023, Opill® is the first-ever daily birth control pill available without a prescription in the U.S.
Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to present at the UBS Global Consumer and Retail Conference in New York City on Wednesday, March 13th at 4:00 PM EST.
Fourth Quarter 2023 Highlights: